med chem @ Arvinas | PhD @ Columbia | hiker | cocktail enthusiast | he/him/huz/dad | dreaming of Sedona | while I have a connection to Arvinas, all opinions expressed are my own and do not represent the views, opinions, or positions of the company

I cover infectious diseases for STAT (www.statnews.com). 2020 Polk winner. Nieman '11. She/her. I write about H5N1 (in all species), Covid, polio, flu, Ebola, RSV, mpox, STIs. Find me on Signal: HBranswell.01

Entrepreneur. Drug hunter. Novice biotech scripophile. Anti-ideologues. Proudly blocked by Vinay Prasad. http://linkedin.com/in/jliang1/

Research Director at Public Citizen's Access to Medicines program. Former journalist covering intersection of pharma, health policy & politics. On Signal at SarahKarlinSmith.34 Views are mine.

Journalist covering biotechnology for MIT Technology Review. Scoops about new methods in genetics and cell biology. The "playing God" beat. Gene editing, gene therapy, ancient DNA, synthetic embryos, cloning, etc.

Entrepreneur and scientist working to make innovative medicines to help patients. Co-founder, Hd of business strategy at Solu Therapeutics. Views my own.

Scientist, entrepreneur, ex-biopharm exec, former FM radio jock, lifelong hockey fan, aspiring guitar player and mixologist, #immigrant. CEO, Arrakis Therapeutics and a variety of other things. https://www.michaelgilman.net/disclosures/

Chief Science and Strategy Officer, openRxiv. Co-Founder, bioRxiv and medRxiv.

Biotech reporter, San Francisco Business Times

Doctor, drug developer, public health leader, runner; fan of Niners, Warriors & Giants.

Healthcare investor. Howard Stern. Arcade Fire. Bowie. U2. California dreamin'

Global HealthCare and Life Sciences investing. Passion for macroeconomics and history.

Senior Fellow at the American Enterprise Institute. Partner, New Enterprise Associates. Contributor CNBC. 23rd Commissioner of the U.S. FDA. Boards: Pfizer, Illumina, TempusAI, United Health

In chronological order - baker, Michigan football fan, data scientist, mom of 2, drug discovery lead, amateur native plant nerd. Personal views only.

MD/PhD | Healthtech & Biopharma Exec | Clinical & scientific judgment at intersection of medicine, biology & technology | Cultivating agency: kindwellhealth.com

Investor in life sciences & tech. Innovation policy. Fellow at Cambridge University (LCC). Married to a better economist. Cooking. Sports, but badly. ICI was the perfect company once

Chief Scientific Officer at Alltrna. Former CSO at Synlogic, Metera Pharmaceuticals and Pulmatrix. Microbiologist, immunologist and drug developer. Opinions are my own.

Entrepreneur, Board Member, Author, Physician Co-founder of nine biotech startups developing novel platforms and therapies. Biotech Board member and advisor; Author of Quiet Leader Loud Results (Post Hill Press, 2022) www.quietleader.com

Health economist writing about HEOR/market access, drug development, biopharma Http://refiningvalue.substack.com

News, stories, and educational videos about the biotechnology sector. Bringing biotech to life. 📺